Appropriate Medication Use in Dutch Terminal Care

The requested reference [99e7b7f0cfdc49e62817b8533477a3cc8c2ae72d] no longer exists in our database. It has been replaced by the current reference: [d801f5c7f653f0d265b5f38b53dd51ba214bb6a1]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The AMUSE trial is a multicentre stepped-wedge cluster randomized controlled trial where medication optimization of patients with a life expectancy of less than three months is investigated by using CDSS-OPTIMED (a personalized medication advice to attending physicians of patients in the last phase of life) The investigators will include 250 patients, in 7 different study sites across the Netherlands. The primary outcome is an assessment of the quality of life of patients, two weeks after baseline assessment.
Epistemonikos ID: d16a64f7ca42ae55b29f5598e2f153a50a2244c8
First added on: May 13, 2024